The CGS Fullgoal Singapore Next 50 Active ETF (SGX: Q50) is an actively managed Singapore equity ETF benchmarked to the iEdge Singapore Next 50 Index.

Its mandate is to hold 30 to 50 SGX-listed stocks selected by a six-factor quantitative model and rebalances monthly, with at least 80% of the portfolio inside the Next 50, balance 20% coming from big STI names.

It is an actively managed exchange traded fund that invests only in Singapore-listed equities, structured as a sub-fund of CGSI Public Markets Solutions VCC.

CGS International Securities Singapore is the Manager. Fullgoal Asset Management (HK) is the Investment Advisor. It trades on the SGX under the code Q50.

Here are the key terms in one place.

The board lot of 1 share means you can just invest in a basket of Next 50 stocks with as low as $1 (per share)!

That’s probably a big win for passive investors…

The iEdge Singapore Next 50 Index tracks the next 50 largest companies listed on the SGX Mainboard after the 30 largest by market capitalisation. It is administered by SGX Index Edge and reviewed quarterly in March, June, September and December.

In plain terms, if the Straits Times Index is the top floor of the Singapore market, the Next 50 is the floor immediately below it. Same building, different tenants.

This matters because of what those tenants are. The 30 largest SGX names skew heavily toward a handful of very large financial institutions.

Step down one tier and the mix broadens considerably, because that is simply what is there: property trusts, manufacturers, healthcare operators, technology suppliers and consumer businesses.

Q50 also references a second index. The MSCI Singapore IMI Index defines a broader pool from which the Manager can select the off-benchmark portion of the portfolio.

Notably, that broader pool does not exclude the 30 largest companies, so Q50 can hold a top-30 name inside its 20% off-benchmark allocation.

CGS Next 50 Active ETF or “Q50” in short, uses a proprietary quantitative multi-factor model that scores every stock in its universe across six factor categories, combines those scores into a single composite alpha score, then feeds the scores into an MSCI Barra Open Optimizer that builds the final portfolio.

The six factors, as described in the offer document, are:

None of these six are novel. They are well-established sources of cross-sectional equity return, which is a point in the model's favour rather than against it.

The interesting part is not the factor list, it is the combination and the constraints applied afterwards.

The portfolio construction rules are specific:

The management fee is 0.65% per annum of fund assets, with a contractual maximum of 1.50%.

Other costs including custodian, registrar and fund administration sit on top, and each may reach or exceed 0.10% per annum.

The Company intends to cap the total expense ratio at 1.50% per annum, with any excess borne by the Manager rather than the fund.

On top of fund-level costs, buying on the exchange carries the usual trading costs:

One detail I appreciate: the management fee is retained by the Manager, and the Manager does not pay trailer fees on this fund.

That removes a distribution incentive that quietly sits inside many unit trusts.

Most retail investors will buy Q50 on the SGX after it lists, in lots of 1 share, through any ordinary brokerage account. During the initial offer period, units are created in blocks of 100,000 shares through Participating Dealers, which puts that route out of reach for typical retail sizes.

There are two routes as per below:

Route 1: the initial offer period. This runs from 6 August 2026 to 11am on 26 August 2026, at S$1.00 per share.

Applications go through placement agents and Participating Dealers, and a Creation Unit is 100,000 shares, in multiples of 50,000. Unless you are writing a six-figure cheque, this is probably not your route.

Route 2: the exchange, after listing. From the expected listing date of 3 September 2026, Q50 trades like any other SGX counter, in board lots of 1 share. This is how nearly every reader of this article will buy it, if they buy it at all.

One more important thing to take note - you can use SRS monies to buy the ETF shares on the SGX thereafter.

Receive bite-sized market updates and actionable stock ideas, so you stay informed without spending hours researching.

A passive STI ETF mechanically tracks the 30 largest SGX-listed companies, a group dominated by large financials. Q50 actively selects 30 to 50 stocks from the tier below that, using a quantitative model, and charges more because it is trying to beat its benchmark rather than match it.

That final row is the honest crux of the whole thing, and I would rather say it plainly than bury it.

Before deciding on any new fund, a good approach I use myself is to look at the underlying holdings.

And what i saw from the picture (thanks to FSM), is that the top 15 holdings (constituting to 77% of portfolio) is mainly made up of Mid cap REITs like Keppel Infrastructure Trust, CapitaLand Ascott Trust, Starhill Global REIT etc.

On top of that, we have the usual Blue Chip Stocks like DBS, Keppel and Venture Corp as “STI Overlay”.

Personally, I was hoping to see some divergence away from REITs/Blue Chip stocks.

Because when you would compare it to the actual iEdge SG Next 50 index (link here), there are a lot more smaller stocks (+ additional eligible stocks) that are ‘lost’ in this Active ETF.

These include popular counters like Pan-United, Propnex, Delfi, Marco Polo Marine etc.

That said, i still applaud the quant scorecard strategy that they will adopt and only actively select the stocks that achieve high composite scores.

The main risks are single-country concentration, the absence of a live track record, active management risk, expense ratio pressure if the fund stays small, and the possibility that the market price of shares differs from net asset value.

If I were tracking this after listing, the two things I would watch are the published net asset value against the iEdge Next 50 benchmark over a full twelve months, and the fund's size. Both are public once it trades, and neither requires guessing today.

Short answers to the questions that come up most often about Q50.

The stock code is Q50, trading in Singapore dollars with a board lot size of 1 share.

Listing is expected at 9am on 3 September 2026, subject to the SGX being satisfied that all listing conditions have been met. The initial offer period runs to 11am on 26 August 2026 and may be extended, in which case any change is announced on SGXNET.

No. It is actively managed. The iEdge Singapore Next 50 Index is its benchmark, meaning the yardstick it is measured against, not a portfolio it replicates.

Yes, but only on the exchange. SRS monies can be used to buy shares on the SGX. They cannot be used for Creation Units during the initial offer period, which must be paid in cash.

The offer document does not state that the fund is a CPFIS included fund. Check the fund's official page or your broker for the current position before assuming CPF eligibility.

The current policy is semi-annual distributions around June and December each year. Both the timing and the amount are at the Company's discretion, and it may retain income for reinvestment instead.

On the exchange after listing, the board lot is 1 share, so the practical minimum is the price of one share plus brokerage. During the initial offer period, a Creation Unit is 100,000 shares in multiples of 50,000.

The offer and issue of shares is conditional on valid subscriptions of at least S$10 million being accepted by the close of the offer period. If that condition is not met and not waived, subscription amounts are returned without interest.

The target holdings range is around 30 to 50 SGX Mainboard stocks, with at least 80% drawn from iEdge Singapore Next 50 constituents.

Q50 gives Singapore investors access to a segment of their own market that most local portfolios underweight, in a tradeable wrapper, at a stated fee well below what comparable active unit trusts charge.

That is genuinely useful, and there is no passive alternative offering the same exposure on the SGX today.

The open question is not whether the segment is interesting. It is whether an active process with no live record here is the right way to buy it, and that is a question the next twelve months of published performance will answer far better than any launch document.

Run the Two-Question Test. Decide on the exposure first. The listing date will still be there afterwards.

Sources: CGS Fullgoal Singapore Next 50 Active ETF Prospectus, registered with the Monetary Authority of Singapore (CGSI Public Markets Solutions VCC, UEN T26VC0066G); iEdge Singapore Next 50 Index methodology, SGX Index Edge.

InvestKaki is a Singapore investing newsletter covering SGX-listed stocks, REITs and ETFs for retail investors, written by James Yeo.

This is general information, not financial advice. It does not take into account your objectives, financial situation or needs. InvestKaki receives sponsorship from brokers and exchange programmes. Do your own research and consider speaking to a licensed financial adviser before investing.